[go: up one dir, main page]

Skip to main content

ASCIA Reports

 

ASCIA Strategic Plan 2024-2028 and ASCIA Priorities Report 2023ASCIA Reports - National Allergy Council Shared Care for Allergy Project | ASCIA Reports - National Allergy Council Schools and Childcare ProjectASCIA AGM Minutes, Annual Reports, Highlights, Financial Reports | ASCIA Scope of Practice documentsNational Allergy Council | ASCIA/NPS Choosing Wisely Australia and RACP Evolve recommendations  | Allergy in Australia 2014 | Allergy and Immune Diseases in Australia (AIDA) Report 2013 | ASCIA Education Resources Report 2013 | Economic Impact of Allergies Report 2007

ASCIA Strategic Plan 2024-2028

ASCIA Strategic Plan 2024 -28ASCIA's purpose is to advance the science and practice of allergy and clinical immunology.  This is achieved by promoting the highest standard of medical practice, training, education and research, to improve the quality of life and health of people with immune system disorders, including allergies, immunodeficiencies and other immune diseases.

pdfASCIA Strategic Plan 2024-2028603.26 KB

In recent years ASCIA has worked on developing Strategies for Allergy and Immunodeficiency, which are now being implemented. These collaborations will be a major focus for ASCIA in the next few years.

To ensure that ASCIA can plan for the future, this new ASCIA Strategic Plan has been developed, based on:

  • ASCIA’s Purpose, Strategic Areas of Focus and Priorities within these areas
  • Findings from the ASCIA Priorities Report 2022-2023
  • National Allergy Council projects assigned to ASCIA
  • ASCIA Immunodeficiency Strategy

ASCIA Priorities Report 2023

ASCIA 2023 Priorities ReportASCIA works towards achieving its purpose by undertaking a wide range of initiatives that are prioritised and are listed at https://www.allergy.org.au/about-ascia/ascia-initiatives

The ASCIA Priorities Report 2023 is based on the results from the ASCIA Member Survey which was conducted from November 2022 to January 2023.  ASCIA undertook to survey the membership to ensure alignment of the ASCIA priorities with member needs. Uptake of the survey was 40% which attests to the enthusiasm and engagement of ASCIA members. 

pdfASCIA Priorities Report 20231.92 MB

ASCIA Reports - National Allergy Council Shared Care for Allergy Project

Report - ASCIA Participation in Medical Conferences 2024

In 2024 ASCIA participated in medical conferences with more than 14,000 delegates, as part of the National Allergy Council Shared Care for Allergy Project.  Read the report here

pdfASCIA REPORT MEDICAL CONFERENCE PARTICIPATION 2024 172.30 KB

Evaluation Reports - ASCIA Anaphylaxis Training for Health Professionals 

For the first time since ASCIA e-training for health professionals was introduced in 2011, reports have been developed based on mandatory feedback surveys. This work has been completed as part of the National Allergy Council Shared Care for Allergy project, and results will guide course updates. 

Highlights from the health professional course reports include:

  • Learning needs met – More than 90% indicated that the full and refresher courses had entirely met their learning needs.
  • Relevant to current practice - 71% indicated that the full course, and 83% indicated that the refresher course was entirely relevant to their current practice.
  • Full course content - 96% indicated nothing was missing and 94% indicated that the course did not need to be improved.
  • Refresher course content - 96% indicated nothing was missing and 95% indicated that the course did not need to be improved.

ASCIA_Anaphylaxis_e-training_for_health_professionals_2023_Report pdfASCIA Anaphylaxis e-training HP Report 2023421.88 KB 

 This report is based on mandatory feedback surveys conducted in 2023

 

ASCIA Anaphylaxis refresher e training for health professionals 2023 Report cover pdfASCIA Anaphylaxis refresher e-training HP Report 2023595.41 KB

 This report on the short refresher version is based on mandatory feedback surveys conducted in 2023

 

The previous report was based on non-mandatory feedback surveys conducted in 2022:

ASCIA Reports - National Allergy Council Schools and Childcare Project

Evaluation Reports - ASCIA Anaphylaxis Training for Schools, Childcare and Community 

For the first time since ASCIA e-training courses for Schools, and Childcare (Children’s Education and Care) were introduced in 2010, reports have been developed based on mandatory feedback surveys in the Australasian (not state specific) versions of the courses. This work has been completed as part of the National Allergy Council Schools and Childcare project and results will guide course updates.

Highlights from the Schools, CEC and Refresher course reports include:

  • Relevant to current role - 81% to 86% indicated that the courses were entirely relevant to their current roles.
  • Course content - 94% to 99% indicated there was nothing missing from the course and 89% to 98% thought that the course content did not need to be improved.

ASCIA Anaphylaxis e training for schools childrens education care and community 2023 Report pdfASCIA Anaphylaxis e-training Schools Report 2023808.11 KB

This report (Schools version) is based on mandatory feedback surveys conducted in 2023

  

ASCIA Anaphylaxis refresher e training for schools childrens educationcare and community 2023 Report pdfASCIA Anaphylaxis e-training CEC Report 2023530.62 KB

This report (Children’s Education and Care version) is based on mandatory feedback surveys conducted in 2023 

 

ASCIA Anaphylaxis refresher e training for schools children's education care and community 2023 Report pdfASCIA Anaphylaxis Refresher e-training Report 2023415.22 KB

This report (Short Refresher version) is based on mandatory feedback surveys conducted in 2023

  

Previous reports were based on non-mandatory feedback surveys conducted in 2022: 

pdfSchools 2022 Report 629.44 KB  | pdfCEC 2022 Report 583.28 KB

ASCIA Immunodeficiency Strategy

ASCIA Immunodeficiency StrategyThe ASCIA  Immunodeficiency Strategy for Australia and New Zealand meeting was held on Friday 28th April, to coincide with World Primary Immunodeficiency Week 2023. The meeting was attended by a range of stakeholders including clinicians (clinical immunologists, specialist nurses and allied health), patient/carer organisations (AusPIPs, IDFA and IDFNZ), and researchers. The meeting was supported by ASCIA and an unrestricted educational grant from CSL Behring. As a result of this meeting a list of proposed prioritised actions was developed which are outlined at https://www.allergy.org.au/about-ascia/info-updates/outcomes-from-ascia-immunodeficiency-strategy-meeting

ASCIA AGM Minutes, Annual Reports, Highlights, Financial Reports

ASCIA Annual General Meeting (AGM) Minutes www.allergy.org.au/members/ascia-agm

ASCIA Annual Reports www.allergy.org.au/members/ascia-annual-reports

ASCIA Annual Highlights www.allergy.org.au/about-ascia/highlights

ASCIA Annual Financial Reports - available on the Australian Charities and Not-for-profits Commission (ACNC) website   

ASCIA Scope of Practice documents

Scope of Practice - Allergy Skin Testing in Australia 2018

ASCIA developed this Scope of Practice  in response to the Medicare Benefits Schedule (MBS) item number changes implemented by the MBS Review Taskforce, effective 1 November 2018.  Whilst these changes were not initiated by ASCIA, the previously proposed item numbers were significantly modified in response to a submission made by ASCIA in July 2017, to ensure patients with complex allergic disease are not disadvantaged.

pdfASCIA Scope of Practice - Allergy Skin Testing in Australia 2018171.23 KB

Scope of Practice - Specialist Physicians in Immunology and Allergy in  Australia 2014

The aim of this Scope of Practice is to outline the range of practice of clinical immunology/allergy specialists in Australia and ensure that patients with allergic and other immune diseases receive the highest standard of care, in line with best clinical practice. 

pdfASCIA Scope of Practice Australia July 2014208.16 KB 

National Allergy Council

From 2014  to 2015 ASCIA developed the National Allergy Strategy, in partnership with Allergy & Anaphyalxis Australia (A&AA), which continues to be implemented through the National Allergy Council.  The Strategy document is available at https://nationalallergycouncil.org.au/about-us/our-strategy   

The National Allergy Council is a partnership between ASCIA and Allergy & Anaphylaxis Australia working in collaboration with other stakeholders. 

ASCIA Recommendations - NPS Choosing Wisely Australia and RACP Evolve 

ASCIA was the first Specialty Society affiliated with the Royal Australasian College of Physicians (RACP) to be involved in Choosing Wisely Australia, a health profession led initiative faciliated by National Prescribing Service (PBS) MedicineWise and the RACP Evolve program.  The ASCIA list of five things that clinicians and consumers should question is available at:

www.choosingwisely.org.au/recommendations/ascia

https://evolve.edu.au/recommendations/ASCIA

For further information about Choosing Wisely Australia go to www.choosingwisely.org.au  

 For further information about the RACP Evolve program go to https://evolve.edu.au/about

Allergy in Australia 2014

 Prior to ASCIA developing a National Allergy Strategy for Australia, the following report was developed in 2014. 

pdfAllergy in Australia 2014: A submission for allergic diseases to be recognised as a National Health Priority Area 606.54 KB

Allergy and Immune Diseases in Australia (AIDA) Report 2013

The AIDA report on allergy and other immune diseases (immunodeficiency and autoimmune diseases) was developed in 2013.

pdfAllergy and Immune Diseases in Australia (AIDA) Report 2013720.33 KB   

ASCIA Education Resources Report 2013

ASCIA has been developing web based education resources since 1999. In 2013, the ASCIA Education Resouces Report was developed to outline the large range of web based educational resources that are all available at no charge on the ASCIA website.

pdfASCIA_Education_Report_July_2013483.57 KB     

Economic Impact of Allergies Report 2007

The cost of allergies to the Australian economy is estimated to be $7.8 billion, with lost productivity and health system expenditure the major contributing factors. Furthermore, most Australians with allergies face a wait many months to see a specialist, if they can access care at all. These are among key findings in the following report 'Economic Impact of Allergies' by Access Economics that was released by ASCIA in November 2007. 

pdfEconomic Impact of Allergies Report - 20071.65 MB 

Content updated November 2024